Austria publishes strategy for life sciences and pharmaceutical sector

27 measures in nine areas have been identified


24 November 2016 – Life sciences and pharma are core areas within Austria’s science, research and business location. At 9.6 billion euros of gross added value, taking indirect and secondary effects into account, the biotech, pharmaceutical and medical technology sector amounts to 2.8% of the Austrian GDP and with a workforce of around 63,000 people makes up about 1.7% of the overall employment.

The present strategy developed by the Federal Ministry of Science, Research and Economy (BMWFW) serves to provide a political commitment to further develop and strengthen Austria’s position as an excellent and internationally competitive location for life sciences and the pharmaceutical sector.


Austrian delegation on life sciences visits Guangdong

Exploring collaboration with South China

2016-08-31_Shenzhen_Shenzhen-Austria Life Science & Biotech Forum

Photo: Prof. Beatrix Kuen-Krismer, Bernhard Koch, Peter Schintlmeister, Dietmar Schwank, Prof. Georg Dorfner, Jürgen Fuchs, Johannes Sarx

30 August 2016 – An Austrian delegation with experts on life sciences, biotechnology and medical technology arrived in Shenzhen after visiting Taipei and began their trip in Guangdong Province.

On 31 August 2016, the Shenzhen-Austria Life Science & Biotech Forum was held in Shenzhen with distinguished guests from the Chinese and Austrian government, organizations and enterprises. After a comprehensive introduction about the life science industry in Shenzhen and Austria, the Austrian delegation had intensive B2B talks with the Chinese participants. Peter Schintlmeister, Counsellor for Science and Technology and director of OSTA, gave a brief overview on Sino-Austrian science and technology cooperation at the forum. In the afternoon, the delegation members had a visit to BGI Genomics company which is one of the world’s most prestigious centers for genetic analysis. On 1 September 2016, the trip was continued in Guangzhou with visit to Guangzhou Institute of Biomedicine and Health (GIBH) and Sun Yat-Sen University. After the fruitful exchange with the Chinese colleagues, the Austrian delegation successfully concluded their visit to Guangdong and left for Shanghai.



Delegation of Invest Shenzhen meets OSTA

Preparing a visit to Austrian research institutes

2016-05-09_Invest Shenzhen_Julia Wang_Yan Kai_Peter Schintlmeister_Li Qiyue_Lu Yunfan

Photo: Julia Wang, Yan Kai, Peter Schintlmeister, Li Qiyue, Lu Yunfan

9 May 2016 – A delegation of Invest Shenzhen visited OSTA in preparation of their journey to Vienna later this month. Invest Shenzhen intends to visit Austrian research institutes and companies mainly in the fields of life sciences, advanced materials and nanotechnology, who are interested in a cooperation with Shenzhen.